Office of Cancer Centers logo

FAQs | Site Map

Policies and Resources

 Policies & Resources

Peer review Image
Organizations with Peer Review Funding Systems Updated on July 13, 2016

As described in this program announcement for P30 Cancer Center Support Grants, eligibility to apply for a CCSG award and to meet the standards for formal CCSG research programs requires specific minimum levels of “peer reviewed, funded research projects.” The NIH and all of the funding organizations listed below employ: 1) a peer review system that uses primarily external reviewers and is free of conflict-of-interest; (2) a ranking or rating system in the review process based on the scientific merit of the proposed research; and (3) a funding system based primarily on the peer review ranking or rating of the research applications. All funded, multi-year research projects from these organizations (excluding pilot projects and feasibility studies) may be counted toward the requirements noted above. In addition, these projects may receive support from CCSG shared resources. More »

  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex's Lemonade Stand Foundation (ALSF)
  3. American Association for Cancer Research (AACR)
  4. American Cancer Society (ACS), (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA), (excluding local/regional and “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program(NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

*Note: Grants funded through the U.S. Army’s, (DOD) special research programs in ovarian, breast and prostate cancer may also be listed in the category of peer reviewed funded grants.

Print Version

NCI-designated Cancer Center Badge NCI-designated Comprehensive Cancer Center Badge
Cancer Center Identity Badges Posted on January 13, 2016

NCI–designated Cancer Centers and NCI–designated Comprehensive Cancer Centers will be allowed to use the Cancer Center Identity Badge, appropriate to their designation, in the promotion, advocacy, educational, and other related activities of the individual cancer center. Cancer Centers and Comprehensive Cancer Centers are not allowed to use the NCI logo.  More »

CTSA Image
Clinical Translational Science Awards Updated on January 1, 2012

Guidance Relevant to NIH Clinical Translational Science Awards (CTSA) and Cancer Center Support Grant (CCSG) Guidelines

Clinical and Translational Science Awards are sponsored by the National Center for Research Resources. CTSAs are intended to complement the extramural programs of other NIH Institutes by creating an academic home for clinical and translational research. The vast majority of institutions with CTSAs also are home to NCI-designated Cancer Centers and issues relevant to the Cancer Center Support Grant (CCSG) Guidelines may arise in some Cancer Centers based on the proposed structure of the CTSA, the organization of the parent institution, and the organization and functions of the Cancer Center. Additional guidance is provided below.

The Six Essential Characteristics As a set of overriding principles, the Six Essential Characteristics, which serve as the cornerstone of the NCI - Cancer Centers Program, remain paramount.

Protocol Review and Monitoring System
Scientific review, prioritization, monitoring, and closure to trials of cancer center clinical trials must continue as exclusive functions of the Protocol Review and Monitoring System of the Cancer Center. It is not acceptable for these functions to be within the purview of the CTSA or any other entity within the parent institution.

Print Version